If you liked this article you might like

Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial

Brainstorm Cell Therapeutics (BCLI) Stock Plummets Ahead of ALS Trial Results

5 Stocks Under $10 Set to Soar

Brainstorm Cell Therapeutics (BCLI) Stock Gains Today on Potentially Positive Phase 2a Results